Keyphrases
Active Surveillance
100%
Clinical Outcomes
100%
Risk Score
100%
Prostate Cancer
100%
Low-risk Prostate Cancer
28%
Adverse Events
28%
Treatment Selection
14%
Biochemical Recurrence
14%
Reasons for Leaving
14%
Molecular Grade
14%
Metastasis
14%
National Comprehensive Cancer Network Guidelines
14%
Prostate Radiotherapy
14%
Patient Preference
14%
Clinical Score
14%
Initial Treatment
14%
Medicine and Dentistry
Cell Cycle
100%
Prostate Cancer
100%
Adverse Event
50%
Biochemical Recurrence
25%
Malignant Neoplasm
25%
Cancer Therapy
25%
Metastatic Carcinoma
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Adverse Event
50%
Biochemical Recurrence
25%
Malignant Neoplasm
25%